Previous close | 6.30 |
Open | 6.31 |
Bid | 6.28 x 400 |
Ask | 6.34 x 500 |
Day's range | 6.03 - 6.34 |
52-week range | 2.68 - 8.22 |
Volume | |
Avg. volume | 366,567 |
Market cap | 200.094M |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Unveiling key financial outcomes and strategic milestones, Capricor Therapeutics sets a robust path for 2024.
Capricor (CAPR) delivered earnings and revenue surprises of -181.82% and 50.93%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...